Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Clinical trial NCT06347003 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06347003
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2026-06-12
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.